

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.75727141 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.75727141 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.49985502 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.49985502 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.90816371 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.69520118 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.52236078 |
| 8 | cysteine metabolic process (GO:0006534) | 5.41024282 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.35829399 |
| 10 | actin-myosin filament sliding (GO:0033275) | 5.34455360 |
| 11 | muscle filament sliding (GO:0030049) | 5.34455360 |
| 12 | lysine metabolic process (GO:0006553) | 5.21150425 |
| 13 | lysine catabolic process (GO:0006554) | 5.21150425 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.19761796 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 5.18836870 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 5.18836870 |
| 17 | tryptophan catabolic process (GO:0006569) | 5.18836870 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.17630601 |
| 19 | kynurenine metabolic process (GO:0070189) | 5.17366817 |
| 20 | tryptophan metabolic process (GO:0006568) | 4.93148150 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90134542 |
| 22 | urea metabolic process (GO:0019627) | 4.82917877 |
| 23 | urea cycle (GO:0000050) | 4.82917877 |
| 24 | actin-mediated cell contraction (GO:0070252) | 4.72448616 |
| 25 | complement activation, alternative pathway (GO:0006957) | 4.66651403 |
| 26 | homocysteine metabolic process (GO:0050667) | 4.64296034 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 4.61686972 |
| 28 | regulation of triglyceride catabolic process (GO:0010896) | 4.59963737 |
| 29 | high-density lipoprotein particle remodeling (GO:0034375) | 4.57640822 |
| 30 | amino-acid betaine metabolic process (GO:0006577) | 4.53158286 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.50911892 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.49355156 |
| 33 | protein carboxylation (GO:0018214) | 4.49355156 |
| 34 | bile acid metabolic process (GO:0008206) | 4.44501428 |
| 35 | serine family amino acid catabolic process (GO:0009071) | 4.44129016 |
| 36 | nitrogen cycle metabolic process (GO:0071941) | 4.43764324 |
| 37 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.43565959 |
| 38 | regulation of fibrinolysis (GO:0051917) | 4.33466052 |
| 39 | ethanol oxidation (GO:0006069) | 4.31856127 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.28496280 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 4.27039464 |
| 42 | regulation of complement activation (GO:0030449) | 4.26380621 |
| 43 | NADH metabolic process (GO:0006734) | 4.25625012 |
| 44 | cellular ketone body metabolic process (GO:0046950) | 4.21960132 |
| 45 | creatine metabolic process (GO:0006600) | 4.20523009 |
| 46 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.20248465 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.16934432 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.13328004 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.13328004 |
| 50 | reverse cholesterol transport (GO:0043691) | 4.11947519 |
| 51 | short-chain fatty acid metabolic process (GO:0046459) | 4.10580198 |
| 52 | regulation of skeletal muscle contraction (GO:0014819) | 4.09422536 |
| 53 | cellular amino acid catabolic process (GO:0009063) | 4.06034590 |
| 54 | cellular modified amino acid catabolic process (GO:0042219) | 4.05393158 |
| 55 | glutamate metabolic process (GO:0006536) | 4.04957379 |
| 56 | myofibril assembly (GO:0030239) | 4.04254010 |
| 57 | blood coagulation, intrinsic pathway (GO:0007597) | 4.02621164 |
| 58 | plasma lipoprotein particle remodeling (GO:0034369) | 4.01786996 |
| 59 | protein-lipid complex remodeling (GO:0034368) | 4.01786996 |
| 60 | macromolecular complex remodeling (GO:0034367) | 4.01786996 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.01736987 |
| 62 | negative regulation of sterol transport (GO:0032372) | 4.01736987 |
| 63 | acetyl-CoA metabolic process (GO:0006084) | 4.01182629 |
| 64 | fatty acid beta-oxidation (GO:0006635) | 3.98916929 |
| 65 | regulation of cholesterol esterification (GO:0010872) | 3.97538584 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 3.97142984 |
| 67 | aspartate family amino acid catabolic process (GO:0009068) | 3.94182005 |
| 68 | coenzyme catabolic process (GO:0009109) | 3.92825800 |
| 69 | carnitine shuttle (GO:0006853) | 3.92409891 |
| 70 | valine metabolic process (GO:0006573) | 3.91516397 |
| 71 | 2-oxoglutarate metabolic process (GO:0006103) | 3.88391957 |
| 72 | fatty acid oxidation (GO:0019395) | 3.88124919 |
| 73 | exogenous drug catabolic process (GO:0042738) | 3.85482001 |
| 74 | cellular glucuronidation (GO:0052695) | 3.84753705 |
| 75 | regulation of relaxation of muscle (GO:1901077) | 3.84677717 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 3.82533890 |
| 77 | fatty acid transmembrane transport (GO:1902001) | 3.82501714 |
| 78 | lipid oxidation (GO:0034440) | 3.81327153 |
| 79 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.79683259 |
| 80 | phospholipid efflux (GO:0033700) | 3.79572129 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.78909564 |
| 82 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.78584095 |
| 83 | drug catabolic process (GO:0042737) | 3.76522952 |
| 84 | cardiac myofibril assembly (GO:0055003) | 3.76231196 |
| 85 | fatty acid catabolic process (GO:0009062) | 3.74547079 |
| 86 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.74098464 |
| 87 | bile acid and bile salt transport (GO:0015721) | 3.72347592 |
| 88 | positive regulation of lipid catabolic process (GO:0050996) | 3.71015389 |
| 89 | organic acid catabolic process (GO:0016054) | 3.70277223 |
| 90 | carboxylic acid catabolic process (GO:0046395) | 3.70277223 |
| 91 | monocarboxylic acid catabolic process (GO:0072329) | 3.69799769 |
| 92 | ketone body metabolic process (GO:1902224) | 3.69124783 |
| 93 | benzene-containing compound metabolic process (GO:0042537) | 3.67305750 |
| 94 | serine family amino acid biosynthetic process (GO:0009070) | 3.64760409 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 3.64363428 |
| 96 | glycine metabolic process (GO:0006544) | 3.63303235 |
| 97 | sarcomere organization (GO:0045214) | 3.62469818 |
| 98 | regulation of cholesterol homeostasis (GO:2000188) | 3.61524736 |
| 99 | carnitine metabolic process (GO:0009437) | 3.61315555 |
| 100 | skeletal muscle contraction (GO:0003009) | 3.58531387 |
| 101 | drug transmembrane transport (GO:0006855) | 3.57897541 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.52317367 |
| 103 | cholesterol efflux (GO:0033344) | 3.50603014 |
| 104 | amine catabolic process (GO:0009310) | 3.49273920 |
| 105 | cellular biogenic amine catabolic process (GO:0042402) | 3.49273920 |
| 106 | plasma lipoprotein particle assembly (GO:0034377) | 3.46539166 |
| 107 | flavonoid metabolic process (GO:0009812) | 3.45026385 |
| 108 | actin filament-based movement (GO:0030048) | 3.43692051 |
| 109 | cholesterol homeostasis (GO:0042632) | 3.41769337 |
| 110 | regulation of cholesterol metabolic process (GO:0090181) | 3.40587343 |
| 111 | glucuronate metabolic process (GO:0019585) | 3.39831266 |
| 112 | uronic acid metabolic process (GO:0006063) | 3.39831266 |
| 113 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.39710342 |
| 114 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.39710342 |
| 115 | branched-chain amino acid catabolic process (GO:0009083) | 3.38960926 |
| 116 | negative regulation of lipase activity (GO:0060192) | 3.38493861 |
| 117 | epoxygenase P450 pathway (GO:0019373) | 3.37920054 |
| 118 | sterol homeostasis (GO:0055092) | 3.37686844 |
| 119 | response to muscle activity (GO:0014850) | 3.34621781 |
| 120 | arginine metabolic process (GO:0006525) | 3.33490503 |
| 121 | ethanol metabolic process (GO:0006067) | 3.32300886 |
| 122 | regulation of lipoprotein metabolic process (GO:0050746) | 3.31133358 |
| 123 | glycogen catabolic process (GO:0005980) | 3.23831733 |
| 124 | striated muscle contraction (GO:0006941) | 3.23756344 |
| 125 | oxaloacetate metabolic process (GO:0006107) | 3.20838751 |
| 126 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.20670938 |
| 127 | carnitine transport (GO:0015879) | 3.19122750 |
| 128 | amino-acid betaine transport (GO:0015838) | 3.19122750 |
| 129 | carnitine transmembrane transport (GO:1902603) | 3.17014639 |
| 130 | regulation of cell communication by electrical coupling (GO:0010649) | 3.12627107 |
| 131 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.10563960 |
| 132 | cellular polysaccharide catabolic process (GO:0044247) | 3.07367146 |
| 133 | glucan catabolic process (GO:0009251) | 3.03581953 |
| 134 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.02211941 |
| 135 | low-density lipoprotein particle remodeling (GO:0034374) | 3.00033353 |
| 136 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.99284778 |
| 137 | intestinal cholesterol absorption (GO:0030299) | 2.97772307 |
| 138 | regulation of sequestering of triglyceride (GO:0010889) | 2.95484006 |
| 139 | actomyosin structure organization (GO:0031032) | 2.94700735 |
| 140 | intestinal absorption (GO:0050892) | 2.93882717 |
| 141 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.90822805 |
| 142 | daunorubicin metabolic process (GO:0044597) | 2.89748401 |
| 143 | polyketide metabolic process (GO:0030638) | 2.89748401 |
| 144 | doxorubicin metabolic process (GO:0044598) | 2.89748401 |
| 145 | cardiac muscle contraction (GO:0060048) | 2.89627169 |
| 146 | tricarboxylic acid cycle (GO:0006099) | 2.88679268 |
| 147 | regulation of actin filament-based movement (GO:1903115) | 2.82877330 |
| 148 | regulation of plasminogen activation (GO:0010755) | 2.81919139 |
| 149 | response to mercury ion (GO:0046689) | 2.77896141 |
| 150 | quaternary ammonium group transport (GO:0015697) | 2.77097952 |
| 151 | negative regulation of protein localization to cell surface (GO:2000009) | 2.76957599 |
| 152 | muscle contraction (GO:0006936) | 2.76180955 |
| 153 | fatty acid homeostasis (GO:0055089) | 2.74955938 |
| 154 | negative regulation of protein activation cascade (GO:2000258) | 2.74881015 |
| 155 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.74059846 |
| 156 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.72344176 |
| 157 | polysaccharide catabolic process (GO:0000272) | 2.71801443 |
| 158 | triglyceride catabolic process (GO:0019433) | 2.70509223 |
| 159 | fibrinolysis (GO:0042730) | 2.64565152 |
| 160 | fructose metabolic process (GO:0006000) | 2.62246287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.38297441 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.40878699 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.26612404 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.85325004 |
| 5 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.38451457 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.52024764 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.95272571 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.72353249 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.98130484 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.82061955 |
| 11 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.45970314 |
| 12 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.31043994 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.03605173 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01472776 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4823143 |
| 16 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95798940 |
| 17 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.86376478 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.75843420 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.73106376 |
| 20 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71798212 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69371286 |
| 22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.68943415 |
| 23 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67463818 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67289105 |
| 25 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.56708455 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52334293 |
| 27 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.48394513 |
| 28 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45836440 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45733881 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43713355 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40435619 |
| 32 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35526648 |
| 33 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35469267 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35047999 |
| 35 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34502072 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33247564 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29980506 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29737554 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26896444 |
| 40 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26504456 |
| 41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.26378765 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26363883 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25415498 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.24956510 |
| 45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.24022103 |
| 46 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.21950650 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.21755670 |
| 48 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.20089058 |
| 49 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18104184 |
| 50 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17470572 |
| 51 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16690349 |
| 52 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13770047 |
| 53 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13621709 |
| 54 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.12792924 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12102365 |
| 56 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12034674 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11079965 |
| 58 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.10267481 |
| 59 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10225156 |
| 60 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10207875 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.09809326 |
| 62 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08847355 |
| 63 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06046354 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04907784 |
| 65 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04794436 |
| 66 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.04538447 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04244008 |
| 68 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03988160 |
| 69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03944877 |
| 70 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03694452 |
| 71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01609285 |
| 72 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01363311 |
| 73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00433757 |
| 74 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99754769 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99056201 |
| 76 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98569102 |
| 77 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98525419 |
| 78 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98409906 |
| 79 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98214280 |
| 80 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98037325 |
| 81 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97460029 |
| 82 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.96490325 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96379736 |
| 84 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96116946 |
| 85 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.95766298 |
| 86 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.94849080 |
| 87 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.94765353 |
| 88 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.94555929 |
| 89 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.94283544 |
| 90 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91834699 |
| 91 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91618201 |
| 92 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91587263 |
| 93 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91306807 |
| 94 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.90702094 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89210268 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89210268 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89177357 |
| 98 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89177357 |
| 99 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.88719350 |
| 100 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.88363651 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88055350 |
| 102 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87880666 |
| 103 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87632491 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.87275657 |
| 105 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.87217809 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.86184368 |
| 107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85979312 |
| 108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85321069 |
| 109 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.82608322 |
| 110 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81117552 |
| 111 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.80782300 |
| 112 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.80720258 |
| 113 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.80372093 |
| 114 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79687044 |
| 115 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79687044 |
| 116 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78705812 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76932070 |
| 118 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76922662 |
| 119 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76688549 |
| 120 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74457183 |
| 121 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.73387475 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73105507 |
| 123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72777822 |
| 124 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72242771 |
| 125 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.72067131 |
| 126 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.70561274 |
| 127 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69997358 |
| 128 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69513185 |
| 129 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.69284527 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67875684 |
| 131 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.67673588 |
| 132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.65593842 |
| 133 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65216594 |
| 134 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64441300 |
| 135 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64380220 |
| 136 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.63969567 |
| 137 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62448427 |
| 138 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61759369 |
| 139 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.61079663 |
| 140 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.60982833 |
| 141 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60669522 |
| 142 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58528221 |
| 143 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57809351 |
| 144 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.56835266 |
| 145 | CBP_21632823_ChIP-Seq_H3396_Human | 0.55756922 |
| 146 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.53017748 |
| 147 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.52558843 |
| 148 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.52208534 |
| 149 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.52204272 |
| 150 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52009295 |
| 151 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.51596320 |
| 152 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.49814128 |
| 153 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.49695802 |
| 154 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49339324 |
| 155 | AR_20517297_ChIP-Seq_VCAP_Human | 0.48797177 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.48439056 |
| 157 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48031223 |
| 158 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.47431099 |
| 159 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46931253 |
| 160 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.46555782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.51824919 |
| 2 | MP0005360_urolithiasis | 7.03018713 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.79918444 |
| 4 | MP0005365_abnormal_bile_salt | 5.70196654 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.58164759 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 3.91642059 |
| 7 | MP0003252_abnormal_bile_duct | 3.78184920 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.75210169 |
| 9 | MP0000751_myopathy | 3.70493817 |
| 10 | MP0003646_muscle_fatigue | 3.50596571 |
| 11 | MP0010329_abnormal_lipoprotein_level | 3.47405667 |
| 12 | MP0004084_abnormal_cardiac_muscle | 3.21142443 |
| 13 | MP0004036_abnormal_muscle_relaxation | 3.09392241 |
| 14 | MP0005083_abnormal_biliary_tract | 3.06233091 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.97281426 |
| 16 | MP0005332_abnormal_amino_acid | 2.91042603 |
| 17 | MP0000749_muscle_degeneration | 2.74381316 |
| 18 | MP0009840_abnormal_foam_cell | 2.73714411 |
| 19 | MP0003195_calcinosis | 2.58245302 |
| 20 | MP0004215_abnormal_myocardial_fiber | 2.56927444 |
| 21 | MP0000013_abnormal_adipose_tissue | 2.26532444 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.25850681 |
| 23 | MP0002106_abnormal_muscle_physiology | 2.22880035 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.20711271 |
| 25 | MP0004087_abnormal_muscle_fiber | 2.19723381 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 2.15458465 |
| 27 | MP0000609_abnormal_liver_physiology | 2.06977879 |
| 28 | MP0005620_abnormal_muscle_contractility | 2.01260785 |
| 29 | MP0005369_muscle_phenotype | 1.90005259 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.87045093 |
| 31 | MP0002269_muscular_atrophy | 1.85265807 |
| 32 | MP0008775_abnormal_heart_ventricle | 1.84896973 |
| 33 | MP0000747_muscle_weakness | 1.84313707 |
| 34 | MP0006138_congestive_heart_failure | 1.83107965 |
| 35 | MP0005319_abnormal_enzyme/_coenzyme | 1.81888635 |
| 36 | MP0000759_abnormal_skeletal_muscle | 1.78300354 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.78272055 |
| 38 | MP0002972_abnormal_cardiac_muscle | 1.76443765 |
| 39 | MP0003868_abnormal_feces_composition | 1.74558011 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.72212907 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.59936214 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.56591113 |
| 43 | MP0004484_altered_response_of | 1.54268800 |
| 44 | MP0001544_abnormal_cardiovascular_syste | 1.52880205 |
| 45 | MP0005385_cardiovascular_system_phenoty | 1.52880205 |
| 46 | MP0004130_abnormal_muscle_cell | 1.48812783 |
| 47 | MP0005670_abnormal_white_adipose | 1.43506281 |
| 48 | MP0003186_abnormal_redox_activity | 1.37484021 |
| 49 | MP0001764_abnormal_homeostasis | 1.34751842 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.24560503 |
| 51 | MP0010630_abnormal_cardiac_muscle | 1.24138867 |
| 52 | MP0002332_abnormal_exercise_endurance | 1.22396711 |
| 53 | MP0002127_abnormal_cardiovascular_syste | 1.22132610 |
| 54 | MP0000750_abnormal_muscle_regeneration | 1.19838656 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.18131043 |
| 56 | MP0003011_delayed_dark_adaptation | 1.18081839 |
| 57 | MP0004085_abnormal_heartbeat | 1.17285777 |
| 58 | MP0002108_abnormal_muscle_morphology | 1.14224347 |
| 59 | MP0005451_abnormal_body_composition | 1.13724817 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 1.09816566 |
| 61 | MP0000598_abnormal_liver_morphology | 1.09227226 |
| 62 | MP0000604_amyloidosis | 1.04981521 |
| 63 | MP0002971_abnormal_brown_adipose | 1.04251045 |
| 64 | MP0010234_abnormal_vibrissa_follicle | 1.03869359 |
| 65 | MP0004272_abnormal_basement_membrane | 1.03527680 |
| 66 | MP0000003_abnormal_adipose_tissue | 1.02888010 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 1.01415120 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.00578029 |
| 69 | MP0004233_abnormal_muscle_weight | 0.99227192 |
| 70 | MP0003941_abnormal_skin_development | 0.95557935 |
| 71 | MP0003122_maternal_imprinting | 0.94451928 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 0.94388440 |
| 73 | MP0001756_abnormal_urination | 0.94313196 |
| 74 | MP0009697_abnormal_copulation | 0.92862129 |
| 75 | MP0005647_abnormal_sex_gland | 0.92319330 |
| 76 | MP0009764_decreased_sensitivity_to | 0.91055906 |
| 77 | MP0003690_abnormal_glial_cell | 0.90389817 |
| 78 | MP0003137_abnormal_impulse_conducting | 0.89590762 |
| 79 | MP0003950_abnormal_plasma_membrane | 0.89321479 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 0.89070896 |
| 81 | MP0002254_reproductive_system_inflammat | 0.89000366 |
| 82 | MP0004043_abnormal_pH_regulation | 0.87588427 |
| 83 | MP0009763_increased_sensitivity_to | 0.87256750 |
| 84 | MP0005334_abnormal_fat_pad | 0.85085836 |
| 85 | MP0009642_abnormal_blood_homeostasis | 0.84959711 |
| 86 | MP0010368_abnormal_lymphatic_system | 0.84533114 |
| 87 | MP0005408_hypopigmentation | 0.84281765 |
| 88 | MP0005535_abnormal_body_temperature | 0.83573985 |
| 89 | MP0005409_darkened_coat_color | 0.83562889 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 0.82990666 |
| 91 | MP0001661_extended_life_span | 0.77738224 |
| 92 | MP0008469_abnormal_protein_level | 0.77343657 |
| 93 | MP0003329_amyloid_beta_deposits | 0.77082218 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.77020394 |
| 95 | MP0003300_gastrointestinal_ulcer | 0.76044394 |
| 96 | MP0002909_abnormal_adrenal_gland | 0.72422964 |
| 97 | MP0009384_cardiac_valve_regurgitation | 0.72201715 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.70466615 |
| 99 | MP0002796_impaired_skin_barrier | 0.69746938 |
| 100 | MP0005448_abnormal_energy_balance | 0.69147830 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.68295053 |
| 102 | MP0005375_adipose_tissue_phenotype | 0.68258548 |
| 103 | MP0001879_abnormal_lymphatic_vessel | 0.67561988 |
| 104 | MP0004134_abnormal_chest_morphology | 0.67212556 |
| 105 | MP0005376_homeostasis/metabolism_phenot | 0.67163931 |
| 106 | MP0002128_abnormal_blood_circulation | 0.65740381 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.64169767 |
| 108 | MP0002638_abnormal_pupillary_reflex | 0.63687748 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.62524325 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.62184727 |
| 111 | MP0000733_abnormal_muscle_development | 0.61314614 |
| 112 | MP0008438_abnormal_cutaneous_collagen | 0.59896476 |
| 113 | MP0004270_analgesia | 0.59205223 |
| 114 | MP0000266_abnormal_heart_morphology | 0.57535566 |
| 115 | MP0005165_increased_susceptibility_to | 0.57514046 |
| 116 | MP0000566_synostosis | 0.56454490 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.55963343 |
| 118 | MP0005266_abnormal_metabolism | 0.55758159 |
| 119 | MP0009115_abnormal_fat_cell | 0.55488162 |
| 120 | MP0001765_abnormal_ion_homeostasis | 0.54341537 |
| 121 | MP0005187_abnormal_penis_morphology | 0.54317037 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.53757406 |
| 123 | MP0003075_altered_response_to | 0.51646632 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.51191993 |
| 125 | MP0009053_abnormal_anal_canal | 0.49824365 |
| 126 | MP0002970_abnormal_white_adipose | 0.49357893 |
| 127 | MP0002928_abnormal_bile_duct | 0.48918731 |
| 128 | MP0003953_abnormal_hormone_level | 0.48670019 |
| 129 | MP0006035_abnormal_mitochondrial_morpho | 0.48521989 |
| 130 | MP0002060_abnormal_skin_morphology | 0.47782227 |
| 131 | MP0005275_abnormal_skin_tensile | 0.46592423 |
| 132 | MP0001881_abnormal_mammary_gland | 0.46023078 |
| 133 | MP0003959_abnormal_lean_body | 0.45611625 |
| 134 | MP0000639_abnormal_adrenal_gland | 0.44728347 |
| 135 | MP0004264_abnormal_extraembryonic_tissu | 0.44515906 |
| 136 | MP0005166_decreased_susceptibility_to | 0.43279737 |
| 137 | MP0005330_cardiomyopathy | 0.42698535 |
| 138 | MP0002168_other_aberrant_phenotype | 0.41865292 |
| 139 | MP0003724_increased_susceptibility_to | 0.41835737 |
| 140 | MP0004147_increased_porphyrin_level | 0.40646193 |
| 141 | MP0005464_abnormal_platelet_physiology | 0.39830571 |
| 142 | MP0004782_abnormal_surfactant_physiolog | 0.39413075 |
| 143 | MP0008961_abnormal_basal_metabolism | 0.39205310 |
| 144 | MP0008872_abnormal_physiological_respon | 0.38626020 |
| 145 | MP0008874_decreased_physiological_sensi | 0.38541156 |
| 146 | MP0000579_abnormal_nail_morphology | 0.37244486 |
| 147 | MP0000538_abnormal_urinary_bladder | 0.36573993 |
| 148 | MP0008873_increased_physiological_sensi | 0.36098210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 7.10871383 |
| 2 | Nemaline bodies (HP:0003798) | 6.91116415 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.78812221 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.38455843 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 6.26723817 |
| 6 | Deep venous thrombosis (HP:0002625) | 6.26186122 |
| 7 | Exercise-induced myalgia (HP:0003738) | 5.86686274 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 5.72430655 |
| 9 | Xanthomatosis (HP:0000991) | 5.64316621 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.60397764 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 5.22726621 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 5.06006157 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 4.97128496 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 4.85537588 |
| 15 | Hyperammonemia (HP:0001987) | 4.77419291 |
| 16 | Complement deficiency (HP:0004431) | 4.69025931 |
| 17 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.55540868 |
| 18 | Ketosis (HP:0001946) | 4.54932602 |
| 19 | Hyperglycinuria (HP:0003108) | 4.46514077 |
| 20 | Rhabdomyolysis (HP:0003201) | 4.35958341 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 4.31350900 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.31350900 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.30618235 |
| 24 | Calf muscle hypertrophy (HP:0008981) | 4.29358006 |
| 25 | Hypoglycemic coma (HP:0001325) | 4.27947352 |
| 26 | Hypolipoproteinemia (HP:0010981) | 4.18218604 |
| 27 | Hyperglycinemia (HP:0002154) | 4.17365083 |
| 28 | Epidermoid cyst (HP:0200040) | 4.02402555 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.91420625 |
| 30 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.88420848 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.85888505 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.81671200 |
| 33 | Sudden death (HP:0001699) | 3.79367915 |
| 34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.76702169 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.75496989 |
| 36 | Distal arthrogryposis (HP:0005684) | 3.74692835 |
| 37 | Abnormality of the calf musculature (HP:0001430) | 3.71307334 |
| 38 | Ketoacidosis (HP:0001993) | 3.70956117 |
| 39 | Fat malabsorption (HP:0002630) | 3.70137225 |
| 40 | Bundle branch block (HP:0011710) | 3.68293257 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.60572025 |
| 42 | EMG: myopathic abnormalities (HP:0003458) | 3.57597570 |
| 43 | Joint hemorrhage (HP:0005261) | 3.56896208 |
| 44 | Hyporeflexia of lower limbs (HP:0002600) | 3.47280089 |
| 45 | Rimmed vacuoles (HP:0003805) | 3.46440729 |
| 46 | Asymmetric septal hypertrophy (HP:0001670) | 3.43752468 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 3.38124814 |
| 48 | Muscle fiber splitting (HP:0003555) | 3.36852907 |
| 49 | Abnormality of complement system (HP:0005339) | 3.33903597 |
| 50 | Abnormality of the intrinsic pathway (HP:0010989) | 3.31220761 |
| 51 | Hypercholesterolemia (HP:0003124) | 3.24656614 |
| 52 | Round ear (HP:0100830) | 3.18143213 |
| 53 | Gout (HP:0001997) | 3.17300816 |
| 54 | Myopathic facies (HP:0002058) | 3.15937674 |
| 55 | Neck muscle weakness (HP:0000467) | 3.13990640 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 3.12594200 |
| 57 | Subaortic stenosis (HP:0001682) | 3.10755898 |
| 58 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.10755898 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 3.06638981 |
| 60 | Hyperbilirubinemia (HP:0002904) | 3.04388000 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.03708401 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 3.03708401 |
| 63 | Delayed CNS myelination (HP:0002188) | 2.97122430 |
| 64 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95041705 |
| 65 | Ulnar deviation of the wrist (HP:0003049) | 2.90781832 |
| 66 | Abnormality of serum amino acid levels (HP:0003112) | 2.90275291 |
| 67 | Metabolic acidosis (HP:0001942) | 2.89368469 |
| 68 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.88025983 |
| 69 | Myocardial infarction (HP:0001658) | 2.79000663 |
| 70 | Steatorrhea (HP:0002570) | 2.77174521 |
| 71 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.77168973 |
| 72 | Hepatocellular carcinoma (HP:0001402) | 2.77069404 |
| 73 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.71847153 |
| 74 | Heart block (HP:0012722) | 2.70567176 |
| 75 | Ventricular tachycardia (HP:0004756) | 2.68985338 |
| 76 | Skin nodule (HP:0200036) | 2.63635977 |
| 77 | Vascular calcification (HP:0004934) | 2.62928472 |
| 78 | Lethargy (HP:0001254) | 2.61403839 |
| 79 | Generalized aminoaciduria (HP:0002909) | 2.58217642 |
| 80 | Muscle stiffness (HP:0003552) | 2.58014624 |
| 81 | Increased variability in muscle fiber diameter (HP:0003557) | 2.57245654 |
| 82 | Dilated cardiomyopathy (HP:0001644) | 2.54034972 |
| 83 | Spastic diplegia (HP:0001264) | 2.52625358 |
| 84 | Abnormal atrioventricular conduction (HP:0005150) | 2.52424980 |
| 85 | Abnormality of proline metabolism (HP:0010907) | 2.51390929 |
| 86 | Hydroxyprolinuria (HP:0003080) | 2.51390929 |
| 87 | EMG: neuropathic changes (HP:0003445) | 2.44090062 |
| 88 | Hypoglycemic seizures (HP:0002173) | 2.41674329 |
| 89 | Esophageal varix (HP:0002040) | 2.41256844 |
| 90 | Cardiovascular calcification (HP:0011915) | 2.40888303 |
| 91 | Atrioventricular block (HP:0001678) | 2.37725425 |
| 92 | Difficulty running (HP:0009046) | 2.36628378 |
| 93 | Acanthocytosis (HP:0001927) | 2.33943300 |
| 94 | Systemic lupus erythematosus (HP:0002725) | 2.32988772 |
| 95 | Lipoatrophy (HP:0100578) | 2.32726863 |
| 96 | Myotonia (HP:0002486) | 2.32021710 |
| 97 | Absent phalangeal crease (HP:0006109) | 2.30839353 |
| 98 | Cerebral edema (HP:0002181) | 2.29538316 |
| 99 | Spontaneous abortion (HP:0005268) | 2.27854879 |
| 100 | Proximal tubulopathy (HP:0000114) | 2.27748527 |
| 101 | Abnormal gallbladder morphology (HP:0012437) | 2.27511309 |
| 102 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.27379262 |
| 103 | Increased purine levels (HP:0004368) | 2.26428721 |
| 104 | Hyperuricemia (HP:0002149) | 2.26428721 |
| 105 | Sensorimotor neuropathy (HP:0007141) | 2.26307702 |
| 106 | Neonatal onset (HP:0003623) | 2.26161322 |
| 107 | Vomiting (HP:0002013) | 2.25164125 |
| 108 | Cholelithiasis (HP:0001081) | 2.24362882 |
| 109 | Late onset (HP:0003584) | 2.23799159 |
| 110 | Frequent falls (HP:0002359) | 2.23435552 |
| 111 | Distal lower limb muscle weakness (HP:0009053) | 2.20707622 |
| 112 | Pancreatitis (HP:0001733) | 2.20045652 |
| 113 | Malnutrition (HP:0004395) | 2.19954847 |
| 114 | Myoglobinuria (HP:0002913) | 2.18143922 |
| 115 | Palpitations (HP:0001962) | 2.17258259 |
| 116 | Back pain (HP:0003418) | 2.15029383 |
| 117 | Cholecystitis (HP:0001082) | 2.13172708 |
| 118 | Abnormal gallbladder physiology (HP:0012438) | 2.13172708 |
| 119 | Abnormal cartilage morphology (HP:0002763) | 2.12351664 |
| 120 | Irritability (HP:0000737) | 2.11724354 |
| 121 | Alkalosis (HP:0001948) | 2.11718114 |
| 122 | Hyperkalemia (HP:0002153) | 2.11226618 |
| 123 | Mitral stenosis (HP:0001718) | 2.07783404 |
| 124 | Generalized muscle weakness (HP:0003324) | 2.07146569 |
| 125 | Amyloidosis (HP:0011034) | 2.05815003 |
| 126 | Hemorrhage of the eye (HP:0011885) | 2.03097967 |
| 127 | Malignant hyperthermia (HP:0002047) | 1.99314701 |
| 128 | Areflexia of lower limbs (HP:0002522) | 1.97306852 |
| 129 | Increased connective tissue (HP:0009025) | 1.97263321 |
| 130 | Brushfield spots (HP:0001088) | 1.95362566 |
| 131 | Calcaneovalgus deformity (HP:0001848) | 1.94993570 |
| 132 | Ventricular arrhythmia (HP:0004308) | 1.94589219 |
| 133 | Glomerulonephritis (HP:0000099) | 1.93805384 |
| 134 | Hypertriglyceridemia (HP:0002155) | 1.93095705 |
| 135 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.92573352 |
| 136 | Cerebral palsy (HP:0100021) | 1.92444907 |
| 137 | Glycosuria (HP:0003076) | 1.91430080 |
| 138 | Abnormality of urine glucose concentration (HP:0011016) | 1.91430080 |
| 139 | Oligomenorrhea (HP:0000876) | 1.90994458 |
| 140 | Syncope (HP:0001279) | 1.90236297 |
| 141 | Abnormal finger flexion creases (HP:0006143) | 1.87278941 |
| 142 | Enlarged kidneys (HP:0000105) | 1.87015059 |
| 143 | Abnormality of the gallbladder (HP:0005264) | 1.84959729 |
| 144 | Atrial fibrillation (HP:0005110) | 1.84016400 |
| 145 | Nausea (HP:0002018) | 1.83491989 |
| 146 | Renal cortical cysts (HP:0000803) | 1.83431643 |
| 147 | Deformed tarsal bones (HP:0008119) | 1.82207168 |
| 148 | Increased serum pyruvate (HP:0003542) | 1.81987303 |
| 149 | Limb-girdle muscle atrophy (HP:0003797) | 1.80258685 |
| 150 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78818511 |
| 151 | Rickets (HP:0002748) | 1.76611667 |
| 152 | Right ventricular cardiomyopathy (HP:0011663) | 1.75970928 |
| 153 | Elevated hepatic transaminases (HP:0002910) | 1.75505099 |
| 154 | Hypochromic microcytic anemia (HP:0004840) | 1.75394214 |
| 155 | Opisthotonus (HP:0002179) | 1.74973441 |
| 156 | Polycythemia (HP:0001901) | 1.72597971 |
| 157 | Menorrhagia (HP:0000132) | 1.72025508 |
| 158 | Hyperglycemia (HP:0003074) | 1.71872015 |
| 159 | Poikilocytosis (HP:0004447) | 1.71299672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.52284919 |
| 2 | BCKDK | 6.15854905 |
| 3 | SIK1 | 4.16200405 |
| 4 | ERN1 | 3.89580701 |
| 5 | TRIB3 | 3.67662267 |
| 6 | FGFR4 | 2.98952686 |
| 7 | PKN2 | 2.88993192 |
| 8 | MST1R | 2.47615848 |
| 9 | FRK | 1.91411861 |
| 10 | INSRR | 1.89036759 |
| 11 | LATS1 | 1.86795948 |
| 12 | PTK6 | 1.85672849 |
| 13 | TRPM7 | 1.85479957 |
| 14 | FGFR2 | 1.79161375 |
| 15 | LMTK2 | 1.78985420 |
| 16 | MAPKAPK3 | 1.78962980 |
| 17 | ERBB4 | 1.70659733 |
| 18 | RIPK1 | 1.57950195 |
| 19 | FLT3 | 1.56789852 |
| 20 | TAOK3 | 1.53951475 |
| 21 | CAMK1D | 1.51680660 |
| 22 | PDK3 | 1.46261908 |
| 23 | PDK4 | 1.46261908 |
| 24 | ERBB3 | 1.46064721 |
| 25 | MAPK11 | 1.33981609 |
| 26 | LIMK1 | 1.32633796 |
| 27 | MAP3K7 | 1.32360872 |
| 28 | MAP2K4 | 1.32047340 |
| 29 | PIK3CG | 1.31517827 |
| 30 | MARK1 | 1.27770144 |
| 31 | NEK9 | 1.27434487 |
| 32 | WNK4 | 1.27163554 |
| 33 | DMPK | 1.14248124 |
| 34 | EPHB1 | 1.13802214 |
| 35 | MET | 1.13554994 |
| 36 | PRKAA2 | 1.12284812 |
| 37 | MUSK | 1.10572327 |
| 38 | LRRK2 | 1.03299724 |
| 39 | TGFBR2 | 1.00516279 |
| 40 | JAK2 | 0.99656866 |
| 41 | TYK2 | 0.99496820 |
| 42 | PDK2 | 0.98094951 |
| 43 | PDGFRA | 0.98023007 |
| 44 | TIE1 | 0.96647489 |
| 45 | AKT3 | 0.94478237 |
| 46 | ERBB2 | 0.91226149 |
| 47 | ABL2 | 0.90250127 |
| 48 | MAP3K10 | 0.89940403 |
| 49 | KDR | 0.89676791 |
| 50 | TTN | 0.89038563 |
| 51 | PINK1 | 0.88392999 |
| 52 | CAMK1G | 0.88060587 |
| 53 | PIK3CA | 0.87149913 |
| 54 | DAPK2 | 0.86748484 |
| 55 | GRK1 | 0.84559917 |
| 56 | CAMK2D | 0.82924877 |
| 57 | RET | 0.82345408 |
| 58 | SGK2 | 0.82049932 |
| 59 | MYLK | 0.80250968 |
| 60 | JAK1 | 0.79621748 |
| 61 | MAP3K3 | 0.79273124 |
| 62 | TBK1 | 0.79134556 |
| 63 | MAP3K2 | 0.78750324 |
| 64 | MAP2K3 | 0.78486440 |
| 65 | PDPK1 | 0.78373870 |
| 66 | PTK2 | 0.77476715 |
| 67 | MAP3K6 | 0.76091652 |
| 68 | MAP2K1 | 0.75834871 |
| 69 | NLK | 0.74553074 |
| 70 | CDK6 | 0.74301966 |
| 71 | OXSR1 | 0.71642656 |
| 72 | PRKAA1 | 0.68493509 |
| 73 | MAPK12 | 0.66948500 |
| 74 | GSK3A | 0.66648733 |
| 75 | BMPR1B | 0.65792510 |
| 76 | FGFR3 | 0.65245887 |
| 77 | MAP2K2 | 0.64594757 |
| 78 | GRK6 | 0.63588040 |
| 79 | DYRK1B | 0.62391371 |
| 80 | MAPK7 | 0.62270246 |
| 81 | DDR2 | 0.61946561 |
| 82 | FER | 0.61038471 |
| 83 | NEK1 | 0.61024235 |
| 84 | PRKCZ | 0.60951817 |
| 85 | PRKACG | 0.60729596 |
| 86 | STK39 | 0.60357460 |
| 87 | PRKG1 | 0.59072715 |
| 88 | SGK3 | 0.57530299 |
| 89 | CAMK2A | 0.57014237 |
| 90 | PRKCE | 0.56448822 |
| 91 | CAMK2G | 0.56362187 |
| 92 | PRKACA | 0.55801026 |
| 93 | PRKG2 | 0.55234384 |
| 94 | EIF2AK3 | 0.55009834 |
| 95 | EEF2K | 0.54749817 |
| 96 | SGK223 | 0.54658869 |
| 97 | SGK494 | 0.54658869 |
| 98 | PDK1 | 0.54478128 |
| 99 | MAPK4 | 0.52904845 |
| 100 | BMX | 0.51863875 |
| 101 | BCR | 0.51433399 |
| 102 | PAK3 | 0.49685940 |
| 103 | WNK1 | 0.49590282 |
| 104 | PRKD1 | 0.48706746 |
| 105 | KSR2 | 0.48606710 |
| 106 | AKT2 | 0.48227984 |
| 107 | LATS2 | 0.47430442 |
| 108 | ROCK1 | 0.47398624 |
| 109 | MAP3K11 | 0.46806473 |
| 110 | EPHB2 | 0.44262841 |
| 111 | MAP3K4 | 0.44037393 |
| 112 | CAMK4 | 0.43798112 |
| 113 | FGFR1 | 0.43325403 |
| 114 | RPS6KB1 | 0.43199509 |
| 115 | MAPK13 | 0.42198778 |
| 116 | CAMKK1 | 0.42140197 |
| 117 | CAMK2B | 0.42061185 |
| 118 | MAP4K2 | 0.41189117 |
| 119 | EPHA3 | 0.41069575 |
| 120 | EIF2AK1 | 0.40652471 |
| 121 | PRKCQ | 0.39493894 |
| 122 | IGF1R | 0.38856756 |
| 123 | MTOR | 0.38154787 |
| 124 | RPS6KA3 | 0.37880937 |
| 125 | CAMK1 | 0.37853846 |
| 126 | PDGFRB | 0.37756395 |
| 127 | MAP2K6 | 0.37293400 |
| 128 | PAK2 | 0.35975567 |
| 129 | STK38L | 0.35547722 |
| 130 | CSK | 0.33584743 |
| 131 | WNK3 | 0.33441511 |
| 132 | PHKG2 | 0.33072345 |
| 133 | PHKG1 | 0.33072345 |
| 134 | PRKACB | 0.32921345 |
| 135 | PRKCH | 0.32571376 |
| 136 | MAP3K1 | 0.32289583 |
| 137 | SCYL2 | 0.31843788 |
| 138 | MAPKAPK5 | 0.31786597 |
| 139 | TGFBR1 | 0.31114548 |
| 140 | STK3 | 0.29789220 |
| 141 | SGK1 | 0.29188265 |
| 142 | STK24 | 0.25984806 |
| 143 | NTRK3 | 0.25601174 |
| 144 | ADRBK2 | 0.25362966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.96363147 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.85345225 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.12505586 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97832913 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.87147001 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.80402906 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74127473 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66244247 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60921032 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56340865 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.51008689 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.29734845 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.22791585 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.20714798 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.20317627 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.11700730 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08867789 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.06384525 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.01296187 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95156142 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.79761905 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78539893 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73012801 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72040203 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69636002 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.66268414 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64197884 |
| 28 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.62840592 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58353672 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.56464236 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.53798921 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51954257 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47285037 |
| 34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.44214113 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.42857697 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.42686077 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.42409613 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.39259346 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.38768687 |
| 40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.38575417 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.37746012 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36614490 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33566985 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.31178741 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30401556 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25533971 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24317603 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19350825 |
| 49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.16139236 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.14788268 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10957320 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.09476423 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.06594053 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 0.99324487 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99036984 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97963956 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94345513 |
| 58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94126201 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.91632340 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91261926 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90774248 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.86100235 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.85296331 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84407379 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.84232595 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82583109 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78550218 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75196598 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74953808 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67134401 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62646510 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.60437267 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.59897027 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58019966 |
| 75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.54446512 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46111732 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42747085 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.41155704 |
| 79 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40514392 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35025038 |
| 81 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.31646521 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29331768 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28350776 |
| 84 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.26805801 |
| 85 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26165290 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.24337679 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23583549 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22827005 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20854015 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.19021556 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.18688244 |
| 92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.17777821 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.16617663 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16569719 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.14876560 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.13669825 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.12805849 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09710084 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.06914418 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.05360591 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.04893590 |
| 102 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03840627 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.02880242 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.00526400 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.00109235 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1483712 |
| 107 | Lysosome_Homo sapiens_hsa04142 | -0.1439269 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1399288 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | -0.1370631 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1364260 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1193948 |
| 112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1096138 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1031767 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | -0.1015488 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1014732 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0942877 |
| 117 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0718347 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0134273 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0107805 |

